首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1629870

全球骨科器材市场 - 2025-2033

Global Orthopedic Devices Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球骨科器械市场规模达585.6亿美元，预计2033年将达到865.6亿美元，2025-2033年预测期间复合年增长率为4.1%。

骨科器械是用于治疗、支撑和替换骨骼、关节和软组织等肌肉骨骼系统组件的专用医疗设备。这些设备对于控制创伤、先天畸形或退化性疾病引起的各种问题至关重要。它们在手术和非手术治疗中都至关重要，可以让患有肌肉骨骼问题的患者更快康復并提高生活品质。除了物理支持之外，矫正器材还可以透过缩短恢復时间和增加復健过程来显着改善患者的治疗效果。特别是在涉及关节置换或骨折固定的手术后，患者在恢復期间经常依赖这些设备来确保适当的癒合和预防问题。

骨科疾病的日益普及是预测期内推动市场的驱动因素。例如，根据美国国立卫生研究院的数据，在美国，50岁以上的人有1,000万人患有髋部骨质疏鬆症。另外 3,360 万名 50 岁以上的人骨量低或髋部骨质减少，使他们在以后的生活中面临骨质疏鬆症和相关问题的风险。

市场动态：

驱动程式和限制

骨科疾病盛行率增加

骨科疾病日益普及率预计将成为全球骨科器械市场成长的重要因素。全球骨科器械市场预计将大幅扩张，这主要是因为骨科疾病盛行率不断上升。这些疾病包括影响肌肉骨骼系统的广泛问题，由于其盛行率不断增加以及对世界各地医疗保健系统产生相应的经济影响，已成为主要的公共卫生问题。由于骨科疾病的数量不断增加，对骨科设备的需求也增加。

例如，根据世界卫生组织的数据，类风湿性关节炎影响全球约 1,800 万人。女性约占类风湿性关节炎患者的 70%，其中 55% 年龄在 55 岁以上。为了减少日益流行的骨科疾病，各大製造商推出了可用于治疗各种骨科疾病的骨科器械。例如，2023 年 2 月，修復弯曲骨折的医疗设备製造商 CurvaFix, Inc. 宣布推出其直径较小的 7.5 毫米 CurvaFix IM 植入体，旨在简化手术并提供坚固、稳定的植入物小骨患者的固定。

机器人手术、电脑辅助手术技术和生物相容性材料的发现改变了骨科领域。这些发展不仅提高了手术精确度，也提高了患者的治疗效果和復原时间。随着医疗保健提供者采用这些新技术，他们将做好更好的准备，以满足对骨科解决方案日益增长的需求。

设备成本高

设备成本高等因素预计将阻碍全球骨科设备市场。全球骨科器械市场面临重大挑战，特别是考虑到这些医疗技术的成本高昂。骨科器械的开发、生产和行销需要大量支出，导致最终用户的价格较高。这种价格负担可能会限制患者获得所需治疗的机会，特别是在医疗资金有限的低收入地区。例如，根据美国国立卫生研究院的数据，从基本设备到高级版本，植入物的成本从 350 美元到 6,370 美元不等。每个案例的平均植入成本为 2,817 美元（范围为 1,250 美元至 7,270 美元）。

Orthopedic devices are specialized medical equipment used to treat, support, and replace musculoskeletal system components such as bones, joints, and soft tissues. These devices are essential for controlling a wide range of problems caused by trauma, congenital abnormalities, or degenerative diseases. They are vital in both surgical and non-surgical treatments, allowing patients with musculoskeletal problems to heal more quickly and improve their quality of life. In addition to physical support, orthopedic devices can considerably enhance patient outcomes by shortening recovery durations and increasing rehabilitation processes. Especially after surgeries involving joint replacements or fracture fixations, patients frequently rely on these devices during their recovery period to guarantee appropriate healing and prevent problems.

The increasing prevalence of orthopedic disorders is the driving factor that drives the market over the forecast period. For instance, according to the National Institute of Health, In the United States, ten million people over the age of fifty suffer from hip osteoporosis. An additional 33.6 million people over the age of 50 have low bone mass or osteopenia of the hip, putting them at risk for osteoporosis and associated problems later in life.

Market Dynamics: Drivers & Restraints

Increasing prevalence of orthopedic disorders

The increasing prevalence of orthopedic disorders is expected to be a significant factor in the growth of the global orthopedic devices market. The global orthopedic devices market is poised for significant expansion, owing mostly to the rising prevalence of orthopedic diseases. These disorders, which include a wide spectrum of problems affecting the musculoskeletal system, have emerged as a major public health concern due to their increasing prevalence and the corresponding economic impact on healthcare systems around the world. Due to the increasing number of orthopedic disorders, the demand for orthopedic devices increases.

For instance, according to the World Health Organization, rheumatoid arthritis affects around 18 million people globally. Women account for around 70% of those with rheumatoid arthritis, with 55% being over the age of 55. Rheumatoid arthritis affects 13 million people, with varying degrees of severity. In order, to reduce the increasing prevalence of orthopedic diseases, major manufacturers have launched orthopedic devices that are useful in the treatment of various orthopedic disorders. For instance, in February 2023, CurvaFix, Inc., a manufacturer of medical devices that repair fractures in bent bones, announced the release of its smaller-diameter, 7.5mm CurvaFix IM Implant, which is intended to simplify surgery and give strong, stable fixation in small-bone patients.

Robotic procedures, computer-assisted surgical techniques, and the discovery of biocompatible materials have transformed the orthopedic landscape. These developments improve not only surgical precision but also patient outcomes and recuperation timelines. As healthcare providers adopt these new technologies, they will be better prepared to meet the growing need for orthopedic solutions.

High costs of devices

Factors such as high costs of devices are expected to hamper the global orthopedic devices market. The worldwide orthopedic devices market meets significant challenges, particularly given the high cost of these medical technologies. The development, production, and marketing of orthopedic devices require significant expenditure, resulting in higher prices for end users. This price burden might limit patient's access to required therapies, particularly in low-income areas where healthcare funds are limited. For instance, according to the National Institute of Health, the costs of implants range from $350 to $6,370 right from the basic device to advanced versions. The average per-case cost for an implant was $2,817 (range $1,250 to $7,270).

Segment Analysis

The global orthopedic devices market is segmented based on product type, application, end-user, and region.

Orthopedic braces segment is expected to dominate the global orthopedic devices market share

The orthopedic braces segment is anticipated to dominate the global orthopedic devices market owing to its essential function in several applications across diverse scientific fields. The orthopedic braces sector is anticipated to dominate the worldwide orthopedic devices market, owing to a number of important factors including rising demand for these devices and their critical role in patient care, technological advances, and new product launches. The increasing prevalence of orthopedic diseases, such as arthritis, osteoporosis, and sports-related injuries, has created a greater demand for appropriate support and stabilization solutions.

For instance, according to the International Osteoporosis Foundation, Osteoporosis is predicted to impact 200 million women worldwide, roughly one-tenth of women aged 60, one-fifth of women aged 70, two-fifths of women aged 80, and two-thirds of women aged 90. Furthermore, technological developments in materials and technology have significantly enhanced the functionality and comfort of orthopedic braces. Lightweight materials, customized fits, and integrated support systems have increased the appeal of these devices to patients and healthcare providers. There are recent launches in which the latest technology is being involved in the device. For instance, in August 2024, Aspen Medical Products introduced the Align Orthosis. Align Orthosis, developed in partnership with spine surgeon Han Jo Kim, MD of the Hospital for Special Surgery, is the first prefabricated TLSO designed to reduce the incidence of proximal junctional kyphosis (PJK) after surgery.

Geographical Analysis

North America is expected to hold a significant position in the global orthopedic devices market share

North America is expected to hold a significant portion of the global orthopedic devices market. North America will likely account for a significant share of the global orthopedic devices market, owing to its well-established healthcare infrastructure, high demand for novel medical devices, and an increasing patient population requiring orthopedic procedures. As osteoarthritis and osteoporosis become more frequent, the demand for effective orthopedic solutions continues to increase, boosting market expansion in this region.

For instance, according to the Bone Health and Osteoporosis Foundation, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone. One in two women and up to one in four men will break a bone in their lifetime due to osteoporosis. For women, the incidence is greater than that of heart attack, stroke, and breast cancer combined. Moreover, according to John Hopkins Medicine, 30% of Caucasian postmenopausal women in the United States have osteoporosis, while 54% have osteopenia. The incidence of deficient bone mass rises with age.

The presence of major players in this region, recent product launches, and FDA approvals make North America hold the highest market share. For instance, in October 2024, Smith+Nephew announced that it had launched its Legion-hinged knee (HK) system with Oxinium implant technology in the United States. This implant technology outperforms both metal durability and ceramic wear resistance, as well as corrosion resistance.

Asia Pacific is growing at the fastest pace in the global orthopedic devices market

The Asia Pacific region is emerging as the fastest-growing market for orthopedic devices, owing to a combination of demographic trends, increased healthcare investment, recent launches, and an increasing prevalence of orthopedic diseases. This growth is largely attributed to the rapid increase in the aging population across countries like China and India, where the demand for orthopedic interventions is surging due to age-related conditions such as osteoarthritis and osteoporosis.

For instance, according to the World Health Organization (WHO), 30% of postmenopausal women suffer from osteoporosis. It has been reported that around six crore people in India have osteoporosis and 80% of them are women. The peak incidence of osteoporosis in India occurs 10 - 20 years earlier than in Western countries.

Competitive Landscape

The major global players in the global orthopedic devices market include Stryker Corporation, Zimmer Biomet, Synthes Inc., Sonoma Orthopaedic Products Inc., Medtronic, Wright Medical Group N.V, Orthofix Medical Inc., Integra LifeSciences, Arthrex Inc., Smith & Nephew plc. among others.

Emerging Players

Stoko, Canary Medical, and Loci Orthopedics among others

Key Developments

In March 2024, Stryker, a global leader in medical technologies, announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets. The newest Gamma system will provide surgeons with the next generation of Stryker's intramedullary nailing system. The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
In October 2023, DePuy Synthes, the orthopedic device business of Johnson & Johnson, has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system. TriLeap offers a wide range of plate options tailored for various procedures and screw diameters, according to DePuy Synthes. Its instruments can be used during the reduction, internal fixation, and fusion of bones and bone fragments.
In August 2023, Enovis Corp. acquired Novastep SAS and its foot and ankle minimally invasive surgical (MIS) platform from Amplitude Surgical SAS for €68 million.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global orthopedic devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Orthopedic Disorders
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Orthopedic Fixation Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Orthopedic Replacement Devices
6.4. Orthopedic Implants and Prosthetics
6.5. Orthopedic Braces
6.6. Implant Surgical Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Fracture Treatment*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Osteoarthritis
7.4. Spinal Disorders
7.5. Sports Injuries
7.6. Osteoporosis
7.7. Cranio-maxillofacial Disorders
7.8. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Stryker Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Zimmer Biomet
11.3. Synthes Inc.
11.4. Sonoma Orthopaedic Products Inc.
11.5. Medtronic
11.6. Wright Medical Group N.V
11.7. Orthofix Medical Inc.
11.8. Integra LifeSciences
11.9. Arthrex Inc.
11.10. Smith & Nephew plc.

LIST NOT EXHAUSTIVE